Exclusives

Urgo has positioned UrgoClean Ag as a tool to be used between sharp debridements in the US. This differs from the European positioning, which doesn’t involve sharp debridement. The variation in positioning is primarily driven by the US...

Convatec noted that there are 2 prospective clinical studies underway in the US for InnovaMatrix on DFU and VLU treatment, which should be completed and published by year end, along with 2 Real World Evidence studies. CTEC Jan-Apr Earnings...

DeRoyal launched its light-deactivated disposable incisional NPWT product at SAWC. The kit comes with 2 dressings that can be used with or without being attached to the NPWT device, which is designed to last 7 days and provide a negative...

Vericel reported the NexoBrid launch is progressing with more than 60 Pharmacy and Therapeutics (P&T) committee submissions, approximately 40 burn centers obtaining approval and more than 30 centers placing initial orders. VCEL Q124 Earnings...

ORGO has a strong RCT for NuShield that's complete and ready for publication. They have a significant amount of real-world data for PuraPly, including a study with over 1,500 patients and have initiated studies with PuraPly AM and PuraPly XT....

Kent Imaging received 510(k) clearance for SnapshotNIR model KD205 for tissue imaging and wound assessment with added features and software upgrades to its current model.

Coloplast noted the latest relevant clinical data on Marigen was omitted from the MAC assessment and will be submitted during the consultation period. It is a 102-patient RCT published in Wounds in April 2023 showing Marigen having superior...

A 100-patient RCT will evaluate the efficacy of a borate-based bioactive glass advanced wound matrix and SoC vs SoC alone with primary outcome of percent of ulcers healed at 12 weeks. Recruitment is ongoing with estimated study completion in...

IART noted that its Integra Skin products are not yet running at full capacity. The demand for the products remain very strong and the company will be working to catch back up to full demand in H224. IART Earnings Transcript on Seeking Alpha